Cataracts in congenital toxoplasmosis

Journal of AAPOS

Volumn 11, Issue 6, 2007, Pages 551-554

  Arun, Veena ^a   Noble, A Gwendolyn ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; PYRIMETHAMINE; SULFADIAZINE;

ANTERIOR EYE SEGMENT; ARTICLE; BIRTH; CATARACT; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONGENITAL TOXOPLASMOSIS; DISEASE COURSE; EYE INJURY; GLAUCOMA; HISTORY; HUMAN; LIFE; MAJOR CLINICAL STUDY; MORBIDITY; MORPHOLOGY; OPHTHALMOLOGY; PATHOLOGY; PERINATAL PERIOD; PHYSICIAN; PRIORITY JOURNAL; RETINA DETACHMENT;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; CATARACT; CATARACT EXTRACTION; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; INCIDENCE; INFANT; LEUCOVORIN; PYRIMETHAMINE; SULFADIAZINE; TOXOPLASMOSIS, CONGENITAL;

EID: 37049003724     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2007.03.017     Document Type: Article

References (15)

1. McLeod R., Boyer K., Karrison T., Kasza K., Swisher C., Roizen N., et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 42 (2006) 1383-1394
2. McAuley J., Boyer K., Patel D., Mets M., Swisher C., Roizen N., et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis. The Chicago Collaborative Treatment Trial. Clin Infect Dis 18 (1994) 38-72
3. Roizen N., Kasza K., Karrison T., Mets M., Noble A.G., Boyer K., et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis. Pediatrics 118 (2006) e379-e390 Epub 2006 Jul 24
4. Eichenwald H.F. A study of congenital toxoplasmosis, with particular emphasis on clinical manifestations, sequelae, and therapy. In: Siim J.C. (Ed). Human Toxoplasmosis (1960), Munksgaard, Copenhagen, Demark 41-49
5. Wilson C.B., Remington J.S., Stagno S., and Reynolds D.W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 66 (1980) 767-774
6. Koppe J.G., Loewer-Sieger D.H., and DeRoever-Bonnet H. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1 (1986) 254-256
7. Saxon S.A., Knight W., Reynolds D.W., Stagno S., and Alford C.A. Intellectual deficits in children born with subclinical congenital toxoplasmosis: A preliminary report. J Pediatr 82 (1973) 792
8. Mets M., Holfels E., Boyer K.M., Swisher C., Roizen N., Stein L., et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122 (1996) 309-324
9. Roizen N., Swisher C., Stein M., Hopkins J., Boyer K.M., Holfels E., et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 95 (1995) 11-20
10. Brezin A.P., Thulliez P., Couvreur J., Nobre R., and McLeod R. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 135 (2003) 779-784
11. Vutova K., Peicheva Z., Popova A., Markova V., Mincheva N., and Todorov T. Congenital toxoplasmosis: Eye manifestations in infants and children. Ann Trop Paediatr 22 (2002) 213-218
12. Dutton G.N. Graefes Clinicopathological features of a congenital murine model of ocular toxoplasmosis. Arch Clin Exp Ophthal 224 (1986) 256-264
13. Nishimoto S., Kawane K., Watanabe-Fukunaga R., Fukuyama H., Ohsawa Y., Uchiyama Y., et al. Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature 424 (2003) 1071-1074
14. Bosch-Driessen L.H., Plaisier M.B., Stilma J.S., Van der Lelij A., and Rothova A. Reactivations of ocular toxoplasmosis after cataract extraction. Ophthalmology 109 (2002) 41-45
15. Westfall A.C., Lauer A.K., Suhler E.B., and Rosenbaum J.T. Toxoplasmosis retinochoroiditis and elevated intraocular pressure: A retrospective study. J Glaucoma 14 (2005) 3-10